Page 768 - Coronavirus Vaccine

India Coronavirus Dispatch: Patent battles can choke Covid drugs pipeline

Efforts to avoid patent battles, a second wave in some cities, fresh research that sheds light on the virus, and more-news on how the country is coping with the pandemic

Covid-19 Factoid: India's cases cross 9 mn but daily spike is dropping

Country's recovery rate is now over 93.6 per cent and the death toll stands at 132,162.

Questionable testing may be the reason India's Covid-19 numbers are down

Rather than showing India is gaining control over Covid-19, the slowing momentum may largely reflect spotty testing levels and a heavy reliance on questionable kits

Coronavirus vaccine: How much it costs, who'll get it first and other FAQs

From Moderna, Pfizer to Oxford and Bharat Biotech coronavirus vaccine candidates, here's all you need to know about Covid-19 shots, who gets them first and what their cost may be

Andaman & Nicobar Islands coronavirus update: 19 new cases reported

Eleven more people tested positive for Covid-19 in the Andaman and Nicobar Islands, pushing the coronavirus tally in the union territory to 4,604

India coronavirus update: Covid-19 caseload in India breaches 9 mn-mark

India's Covid-19 caseload surpassed the 9 mn-mark on Friday with 45,882 new cases, while the recoveries surged to 8.4 mn pushing the national recovery rate to 93.6%

Nasal spray to protect against coronavirus ready for use in humans

A nasal spray that can provide effective protection against the Covid-19 has been developed by researchers at the University of Birmingham, using materials already cleared for use in humans

How sophisticated mRNA vaccines from Pfizer, Moderna are and how they work?

Pfizer-BioNTech vaccine candidate, BNT162b2, was 90% effective in preventing infection during the phase 3 clinical trial, which enrolled 43,538 participants, with 30% in U.S. and 42% abroad

Meghalaya's coronavirus tally nears 11,000-mark, death toll at 104

Meghalaya reported 109 fresh Covid-19 cases, pushing the tally to 10,979

Germany coronavirus update: 22,609 new Covid cases take tally to 855,916

Germany has recorded 22,609 fresh coronavirus cases, taking the tally in the country to 855,916, the Robert Koch Institute (RKI) said

Assam coronavirus update: No Covid-19 deaths in Assam after 14 days

Assam reported no Covid-19 deaths after 14 days, while 175 new cases were detected taking the tally to 211,040

Technology will help us vaccinate large population in short time: PM Modi

PM Narendra Modi told India Inc that the country is uniquely positioned to leap ahead in the information era

G20 leaders urge to provide funds for Covid-19 vaccines, drugs, tests

The letter also called on G20 leaders to commit jointly to "a proportion of future stimulus" spending on the tools, which are particularly aimed at securing supplies for lower income countries

Covid-19 vaccine should be available for public by April 2021: Serum CEO

Probably by 2024, every Indian will get vaccinated, he said at the Hindustan Times Leadership Summit

Extremely bullish outlook for emerging markets: JPMorgan's Gabriela Santos

Gabriela Santos, a global market strategist at the firm's investment arm, said the asset class will benefit from a cyclical recovery in the global economy, buoyed by advances in Covid-19 vaccines

Gold takes a knock amid exodus from ETFs, progress on Covid vaccines

Since hitting a record in August, bullion's rally has stalled amid uncertainty over further stimulus measures and optimism over an effective vaccine, even as the virus continues to spread

Infosys' Simplus joins Sales for vaccine management cloud solution

The solution has been built on the Salesforce Platform in support of Salesforce Work.com for Vaccines as the COVID-19 pandemic continues

500 mn Covid vaccine doses to be made available by Aug: Harsh Vardhan

India's coronavirus caseload mounted to 89,58,483 on Thursday with 45,576 infections being reported in a day, while the death toll climbed to 1,31,578 with 585 new fatalities

Oxford-AstraZeneca Covid-19 vaccine shows immune response in older adults

The vaccine causes few side effects and provokes a response in T-cells that target the virus within 14 days of the first dose and a protective antibody response within 28 days of the booster dose

Covid LIVE: Vaccine should be available for public by April 2021, Serum CEO

Coronavirus update: Maharashtra has 1,757,520 coronavirus cases, Karnataka 865,931, Andhra Pradesh 857,395, Tamil Nadu 763,282 and Kerala 539,919. Stay tuned for coronavirus India LIVE updates